32 filings · most recent first
GH 8-K Filings
Guardant Health Reports Strong Q2 2026 Results And Raises Revenue Guidance
Guardant Health Announces Election Of Directors And Auditor Ratification At
Guardant Health Reports 48 Revenue Growth And Raises 2026 Guidance
Guardant Health Reports 39 Revenue Growth For 2025 And Outlook For 2026
Guardant Health Announces Resignation Of Chief Medical Officer
Guardant Health Announces Strong Revenue Growth For 2025
Guardant Health Reports Strong Q3 2025 Results And Raises Fullyear Guidance
Guardant Health To Host Investor Day On September 24 2025
Guardant Health Appoints Former Hhs Secretary Alex M Azar Ii To Board Of
Guardant Health Reports Strong Q2 2025 Results And Raises Annual Revenue
Guardant Health Reports Strong Q1 2025 Financial Results And Raises Revenue
Guardant Health Reports Strong 2024 Revenue Growth And Provides 2025 Outlook
Guardant Health Reports 34 Revenue Growth In Q3 2024 And Raises Annual Guidance
Guardant Health Reports Strong Q2 2024 Results And Raises Revenue Guidance
Guardant Health Announces 31 Revenue Growth And Raises 2024 Guidance
Guardant Health Reports 2023 Financial Results And Provides 2024 Outlook
Guardant Health Announces Upsized Public Offering And Convertible Notes Offering
Guardant Health Inc Announces Results Of Annual Stockholder Meeting
Guardant Health Extends Lease Agreement
Guardant Health Inc Exchanges New Convertible Senior Notes For Existing Notes
Guardant Health Announces Debt Exchange And New Notes Issuance
Guardant Health Announces Preliminary 2024 Financial Results And Regulation Fd
Roberto A Mignone Joins Guardant Health Board Of Directors
Guardant Health Announces Open Market Sale Agreement Up To 400 Million
Guardant Healths Shield Blood Test Approved By Fda For Crc Screening
Guardant Health Appoints Dr Manuel Hidalgo Medina To Board Of Directors
Guardant Health Announces Results Of Annual Meeting
Guardant Health Amends Executive Severance Plan
Fda Advisory Committee Strongly Recommends Approval Of Guardant Healths Shield
Guardant Health Amends Ceo Compensation Agreements
Guardant Health Board Member Resigns
Guardant Health Announces Preliminary 2023 Financial Results